Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
9
×
Tags
biotech
9
×
national blog main
9
×
san francisco blog main
9
×
life sciences
san francisco top stories
national top stories
new york blog main
raleigh-durham blog main
boston blog main
cancer
cancer diagnostics
national
raleigh-durham top stories
san diego blog main
san francisco
startups
boston top stories
boulder/denver blog main
clinical trials
deals
detroit blog main
detroit top stories
medical device
merck
san diego top stories
seattle blog main
seattle top stories
wisconsin blog main
abbvie
arvinas
boulder/denver top stories
detroit
drug development
fda
freenome
glaxosmithkline
grail
guardant health
indiana blog main
indiana top stories
What
company
9
×
developing
ipo
medical
plans
tests
week
based
blood
cancer
ceo
close
drugs
files
firms
life
make
medicine
pfizer
public
science
treatment
acquisitions
adding
adds
advance
aims
albert
analyzes
ann
announced
arbor
area
bay
biggest
bio
biology
biopsy
biotechs
bourla
Language
unset
unknown
Current search:
photo
×
biotech
×
" national blog main "
×
" san francisco blog main "
×
company
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO
@xconomy.com
6 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round